| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
serine peptidase inhibitor Kazal type 1 | 0.492 | 0.808 | 0.31 |
|
disease | 0.410 | None | 1.000 | 1 | 0 | 2003 | 2009 | ||||||||
|
TSC complex subunit 2 | 0.439 | 0.808 | 1.00 |
|
disease | 0.410 | None | 1.000 | 1 | 0 | 2005 | 2010 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.370 | None | 1.000 | 1 | 0 | 2000 | 2018 | ||||||||
|
palladin, cytoskeletal associated protein | 0.628 | 0.615 | 5.3E-06 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2006 | 2015 | ||||||||
|
RB transcriptional corepressor 1 | 0.444 | 0.885 | 1.00 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 1996 | 2011 | ||||||||
|
AKT serine/threonine kinase 2 | 0.474 | 0.769 | 0.64 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2002 | 2012 | ||||||||
|
transglutaminase 2 | 0.445 | 0.808 | 6.8E-18 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2007 | 2018 | ||||||||
|
tissue factor pathway inhibitor 2 | 0.521 | 0.769 | 8.4E-04 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2006 | ||||||||
|
somatostatin receptor 1 | 0.606 | 0.615 | 0.75 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2008 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2016 | ||||||||
|
interleukin 24 | 0.498 | 0.769 | 5.9E-07 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
FXYD domain containing ion transport regulator 3 | 0.682 | 0.423 | 1.0E-05 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
RAP1 GTPase activating protein | 0.626 | 0.500 | 0.84 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2012 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2003 | 2008 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.220 | None | 0.667 | 1 | 0 | 1997 | 2003 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 2008 | 2012 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.130 | None | 1.000 | 1 | 0 | 1996 | 2013 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
disease | 0.120 | None | 1.000 | 1 | 0 | 2009 | 2014 | ||||||||
|
von Hippel-Lindau tumor suppressor | 0.443 | 0.846 | 8.0E-02 |
|
disease | 0.120 | None | 1.000 | 1 | 0 | 2005 | 2010 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.080 | None | 1.000 | 1 | 0 | 2006 | 2014 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 2005 | 2015 | ||||||||
|
Pim-3 proto-oncogene, serine/threonine kinase | 0.621 | 0.654 | 0.98 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 2009 | 2016 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
syndecan 1 | 0.445 | 0.769 | 8.4E-03 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2000 | 2015 |